This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mather, K. J. Articles by Baron, A. D. Search for Related Content PubMed PubMed Citation Articles by Mather, K. J. Articles by Baron, A. D.

Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications

Indiana University School of Medicine (K.J.M., A.E.H., H.O.S., G.P., G.H., A.D.B.), Division of Endocrinology and Metabolism, Indianapolis, Indiana 46250; and Hypertension-Endocrine Branch (A.K., M.J.Q.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Kieren J. Mather, M.D., FRCPC, Division of Endocrinology, Indiana University School of Medicine, CL 459, 541 North Clinical Drive, Indianapolis, Indiana 46202. E-mail: kmather{at}iupui.edu

Abstract

The objectives of this study were to evaluate test characteristics, such as normality of distribution, variation, and repeatability, of simple fasting measures of insulin sensitivity and to use the results to choose among these measures. Duplicate fasting samples of insulin and glucose were collected before 4 h of euglycemic hyperinsulinemic clamping using insulin infusion rates ranging from 40–600 mU/m²·min. Currently recommended estimates of insulin sensitivity, including the fasting insulin, 40/insulin, the homeostasis model assessment, the logarithmic transformation of the homeostasis model assessment, and the Quantitative Insulin Sensitivity Check Index, were evaluated. The normality of distribution and the variability of the tests (coefficient of variation and discriminant ratio) were compared between the measures and against the "gold standard" hyperinsulinemic clamp. Data from 253 clamp studies in 152 subjects were examined, including 79 repeated studies for repeatability analysis. In subjects ranging from lean to diabetic, the log transformed fasting measures combining insulin and glucose had normal distributions and test characteristics superior to the other simple indices (logarithmic transformation of the homeostasis model assessment coefficient of variation, 0.55; discriminant ratio, 13; Quantitative Insulin Sensitivity Check Index coefficient of variation, 0.05; discriminant ratio, 10) and statistically comparable to euglycemic hyperinsulinemic clamps (coefficient of variation, 0.10; discriminant ratio, 6.4). These favorable characteristics helped explain the superior correlations of these measures with the hyperinsulinemic clamps among insulin-resistant subjects. Furthermore, therapeutic changes in insulin sensitivity were as readily demonstrated with these simple measures as with the hyperinsulinemic clamp. The test characteristics of the logarithmic transformation of the homeostasis model assessment and the Quantitative Insulin Sensitivity Check Index are superior to other simple indices of insulin sensitivity. This helps explain their excellent correlations with formal measures both at baseline and with changes in insulin sensitivity and supports their broader application in clinical research.

This article has been cited by other articles:

				J. Cacho, J. Sevillano, J. de Castro, E. Herrera, and M. P. Ramos Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1269 - E1276. [Abstract] [Full Text] [PDF]

				S A Harrison, D Oliver, H L Arnold, S Gogia, and B A Neuschwander-Tetri Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease Gut, October 1, 2008; 57(10): 1441 - 1447. [Abstract] [Full Text] [PDF]

				S. K. Hutchison, C. Harrison, N. Stepto, C. Meyer, and H. J. Teede Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome Diabetes Care, July 1, 2008; 31(7): 1427 - 1432. [Abstract] [Full Text] [PDF]

				J Polak, Z Kovacova, C Holst, C Verdich, A Astrup, E Blaak, K Patel, J M Oppert, D Langin, J A Martinez, et al. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. Eur. J. Endocrinol., April 1, 2008; 158(4): 533 - 541. [Abstract] [Full Text] [PDF]

				Y. B. Sverrisdottir, T. Mogren, J. Kataoka, P. O. Janson, and E. Stener-Victorin Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E576 - E581. [Abstract] [Full Text] [PDF]

				S. Lee, R. Muniyappa, X. Yan, H. Chen, L. Q. Yue, E.-G. Hong, J. K. Kim, and M. J. Quon Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E261 - E270. [Abstract] [Full Text] [PDF]

				R. Muniyappa, S. Lee, H. Chen, and M. J. Quon Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E15 - E26. [Abstract] [Full Text] [PDF]

				B. Ugur-Altun, A. Altun, S. Guldiken, E. Tatli, M. Kara, and A. Tugrul Silent Myocardial Ischemia in Middle-Aged Asymptomatic Patients With Type 2 Diabetes in Turkish Population Angiology, November 1, 2007; 58(5): 535 - 542. [Abstract] [PDF]

				P. Velasquez-Mieyer, C. P. Neira, R. Nieto, and P. A. Cowan Review: Obesity and cardiometabolic syndrome in children Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 61 - 81. [Abstract] [PDF]

				A. Zanchi, A. G. Dulloo, C. Perregaux, J.-P. Montani, and M. Burnier Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E91 - E95. [Abstract] [Full Text] [PDF]

				A. Zanchi, C. Perregaux, M. Maillard, D. Cefai, J. Nussberger, and M. Burnier The PPAR{gamma} agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1228 - E1234. [Abstract] [Full Text] [PDF]

				E. Barinas-Mitchell, L. H. Kuller, K. Sutton-Tyrrell, R. Hegazi, P. Harper, J. Mancino, and D. E. Kelley Effect of Weight Loss and Nutritional Intervention on Arterial Stiffness in Type 2 Diabetes Diabetes Care, October 1, 2006; 29(10): 2218 - 2222. [Abstract] [Full Text] [PDF]

				A. Gambineri, V. Vicennati, S. Genghini, F. Tomassoni, U. Pagotto, R. Pasquali, and B. R. Walker Genetic Variation in 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Predicts Adrenal Hyperandrogenism among Lean Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2295 - 2302. [Abstract] [Full Text] [PDF]

				N. Chalasani, R. Vuppalanchi, N. S. Raikwar, and M. A. Deeg Glycosylphosphatidylinositol-Specific Phospholipase D in Nonalcoholic Fatty Liver Disease: A Preliminary Study J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2279 - 2285. [Abstract] [Full Text] [PDF]

				T. Tang, J. Glanville, C. J. Hayden, D. White, J. H. Barth, and A. H. Balen Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study Hum. Reprod., January 1, 2006; 21(1): 80 - 89. [Abstract] [Full Text] [PDF]

				C. S. Fox, M. G. Larson, E. P. Leip, J. B. Meigs, P. W.F. Wilson, and D. Levy Glycemic Status and Development of Kidney Disease: The Framingham Heart Study Diabetes Care, October 1, 2005; 28(10): 2436 - 2440. [Abstract] [Full Text] [PDF]

				S. A.R. Doi, M. Al-Zaid, P. A. Towers, C. J. Scott, and K. A.S. Al-Shoumer Irregular cycles and steroid hormones in polycystic ovary syndrome Hum. Reprod., September 1, 2005; 20(9): 2402 - 2408. [Abstract] [Full Text] [PDF]

				A.A. Lteif, K. Han, and K.J. Mather Obesity, Insulin Resistance, and the Metabolic Syndrome: Determinants of Endothelial Dysfunction in Whites and Blacks Circulation, July 5, 2005; 112(1): 32 - 38. [Abstract] [Full Text] [PDF]

				R. J. Karne, H. Chen, G. Sullivan, and M. J. Quon Letter re: Limited Accuracy of Surrogates of Insulin Resistance during Puberty in Obese and Lean Children at Risk for Altered Glucoregulation J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4418 - 4419. [Full Text] [PDF]

				A. Gambineri, L. Patton, R. De Iasio, B. Cantelli, G. E. Cognini, M. Filicori, A. Barreca, E. Diamanti-Kandarakis, U. Pagotto, and R. Pasquali Efficacy of Octreotide-LAR in Dieting Women with Abdominal Obesity and Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3854 - 3862. [Abstract] [Full Text] [PDF]

				H. Chen, G. Sullivan, and M. J. Quon Assessing the Predictive Accuracy of QUICKI as a Surrogate Index for Insulin Sensitivity Using a Calibration Model Diabetes, July 1, 2005; 54(7): 1914 - 1925. [Abstract] [Full Text] [PDF]

				K. K. Koh, S. H. Han, M. J. Quon, J. Yeal Ahn, and E. K. Shin Beneficial Effects of Fenofibrate to Improve Endothelial Dysfunction and Raise Adiponectin Levels in Patients With Primary Hypertriglyceridemia Diabetes Care, June 1, 2005; 28(6): 1419 - 1424. [Abstract] [Full Text] [PDF]

				K. K. Koh, M. J. Quon, S. H. Han, J. Y. Ahn, D. K. Jin, H. S. Kim, D. S. Kim, and E. K. Shin Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes Hypertension, June 1, 2005; 45(6): 1088 - 1093. [Abstract] [Full Text] [PDF]

				V. Jayagopal, E. S. Kilpatrick, S. Holding, P. E. Jennings, and S. L. Atkin Orlistat Is as Beneficial as Metformin in the Treatment of Polycystic Ovarian Syndrome J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 729 - 733. [Abstract] [Full Text] [PDF]

				R. J. Huggett, J. Burns, A. F. Mackintosh, and D. A.S.G. Mary Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension Hypertension, December 1, 2004; 44(6): 847 - 852. [Abstract] [Full Text] [PDF]

				S. Engeli, J. Janke, K. Gorzelniak, J. Bohnke, N. Ghose, C. Lindschau, F. C. Luft, and A. M. Sharma Regulation of the nitric oxide system in human adipose tissue J. Lipid Res., September 1, 2004; 45(9): 1640 - 1648. [Abstract] [Full Text] [PDF]

				A. Gambineri, C. Pelusi, E. Manicardi, V. Vicennati, M. Cacciari, A. M. Morselli-Labate, U. Pagotto, and R. Pasquali Glucose Intolerance in a Large Cohort of Mediterranean Women With Polycystic Ovary Syndrome: Phenotype and Associated Factors Diabetes, September 1, 2004; 53(9): 2353 - 2358. [Abstract] [Full Text] [PDF]

				S. H. Kim, F. Abbasi, and G. M. Reaven Impact of Degree of Obesity on Surrogate Estimates of Insulin Resistance Diabetes Care, August 1, 2004; 27(8): 1998 - 2002. [Abstract] [Full Text] [PDF]

				R. J. Karne, H. Chen, and M. J. Quon Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism: Response to Ascaso et al. Diabetes Care, May 1, 2004; 27(5): 1247 - 1248. [Full Text] [PDF]

				A. Zanchi, A. Chiolero, M. Maillard, J. Nussberger, H.-R. Brunner, and M. Burnier Effects of the Peroxisomal Proliferator-Activated Receptor-{gamma} Agonist Pioglitazone on Renal and Hormonal Responses to Salt in Healthy Men J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1140 - 1145. [Abstract] [Full Text] [PDF]

				H. Yokoyama, M. Emoto, S. Fujiwara, K. Motoyama, T. Morioka, M. Komatsu, H. Tahara, H. Koyama, T. Shoji, M. Inaba, et al. Quantitative Insulin Sensitivity Check Index and the Reciprocal Index of Homeostasis Model Assessment Are Useful Indexes of Insulin Resistance in Type 2 Diabetic Patients with Wide Range of Fasting Plasma Glucose J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1481 - 1484. [Abstract] [Full Text] [PDF]

				R. M.A. Henry, P. J. Kostense, J. M. Dekker, G. Nijpels, R. J. Heine, O. Kamp, L. M. Bouter, and C. D.A. Stehouwer Carotid Arterial Remodeling: A Maladaptive Phenomenon in Type 2 Diabetes but Not in Impaired Glucose Metabolism: The Hoorn Study Stroke, March 1, 2004; 35(3): 671 - 676. [Abstract] [Full Text] [PDF]

				C. Dos Santos, D. Fallin, C. Le Stunff, S. LeFur, and P. Bougneres INS VNTR is a QTL for the insulin response to oral glucose in obese children Physiol Genomics, February 13, 2004; 16(3): 309 - 313. [Abstract] [Full Text] [PDF]

				R. M.A. Henry, O. Kamp, P. J. Kostense, A. M.W. Spijkerman, J. M. Dekker, R. van Eijck, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer Left Ventricular Mass Increases With Deteriorating Glucose Tolerance, Especially in Women: Independence of Increased Arterial Stiffness or Decreased Flow-Mediated Dilation: The Hoorn Study Diabetes Care, February 1, 2004; 27(2): 522 - 529. [Abstract] [Full Text] [PDF]

				R. J. Huggett, E. M. Scott, S. G. Gilbey, J. B. Stoker, A. F. Mackintosh, and D. A.S.G. Mary Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension Circulation, December 23, 2003; 108(25): 3097 - 3101. [Abstract] [Full Text] [PDF]

				J. Sheeder, S. H. Travers, and C. Stevens-Simon Is This Patient Insulin Resistant? How Much Does It Matter? Clinical Pediatrics, November 1, 2003; 42(9): 835 - 839. [PDF]

				R. Rabasa-Lhoret, J.-P. Bastard, V. Jan, P.-H. Ducluzeau, F. Andreelli, F. Guebre, J. Bruzeau, C. Louche-Pellissier, C. MaItrepierre, J. Peyrat, et al. Modified Quantitative Insulin Sensitivity Check Index Is Better Correlated to Hyperinsulinemic Glucose Clamp than Other Fasting-Based Index of Insulin Sensitivity in Different Insulin-Resistant States J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4917 - 4923. [Abstract] [Full Text] [PDF]

				U. Pagotto, A. Gambineri, C. Pelusi, S. Genghini, M. Cacciari, B. Otto, T. Castaneda, M. Tschop, and R. Pasquali Testosterone Replacement Therapy Restores Normal Ghrelin in Hypogonadal Men J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4139 - 4143. [Abstract] [Full Text] [PDF]

				H. Yokoyama, M. Emoto, S. Fujiwara, K. Motoyama, T. Morioka, M. Komatsu, H. Tahara, T. Shoji, Y. Okuno, and Y. Nishizawa Quantitative Insulin Sensitivity Check Index and the Reciprocal Index of Homeostasis Model Assessment in Normal Range Weight and Moderately Obese Type 2 Diabetic Patients Diabetes Care, August 1, 2003; 26(8): 2426 - 2432. [Abstract] [Full Text] [PDF]

				M. Ferin, M. Morrell, E. Xiao, L. Kochan, F. Qian, T. Wright, and M. Sauer Endocrine and Metabolic Responses to Long-Term Monotherapy with the Antiepileptic Drug Valproate in the Normally Cycling Rhesus Monkey J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2908 - 2915. [Abstract] [Full Text] [PDF]

				E. V. Polyzogopoulou, F. Kalfarentzos, A. G. Vagenakis, and T. K. Alexandrides Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery Diabetes, May 1, 2003; 52(5): 1098 - 1103. [Abstract] [Full Text] [PDF]

				M. Schachter, A. Raziel, S. Friedler, D. Strassburger, O. Bern, and R. Ron-El Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine Hum. Reprod., April 1, 2003; 18(4): 721 - 727. [Abstract] [Full Text] [PDF]

				S. Engeli, M. Feldpausch, K. Gorzelniak, F. Hartwig, U. Heintze, J. Janke, M. Mohlig, A. F.H. Pfeiffer, F. C. Luft, and A. M. Sharma Association Between Adiponectin and Mediators of Inflammation in Obese Women Diabetes, April 1, 2003; 52(4): 942 - 947. [Abstract] [Full Text] [PDF]

				H. Chen, G. Sullivan, L. Q. Yue, A. Katz, and M. J. Quon QUICKI is a useful index of insulin sensitivity in subjects with hypertension Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E804 - E812. [Abstract] [Full Text] [PDF]

				A. J.G. Hanley, K. Williams, C. Gonzalez, R. B. D'Agostino Jr, L. E. Wagenknecht, M. P. Stern, and S. M. Haffner Prediction of Type 2 Diabetes Using Simple Measures of Insulin Resistance: Combined Results From the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study Diabetes, February 1, 2003; 52(2): 463 - 469. [Abstract] [Full Text] [PDF]

				M. K. Rutter, H. Parise, E. J. Benjamin, D. Levy, M. G. Larson, J. B. Meigs, R. W. Nesto, P. W.F. Wilson, and R. S. Vasan Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study Circulation, January 28, 2003; 107(3): 448 - 454. [Abstract] [Full Text] [PDF]

				A. Katsuki, Y. Sumida, H. Urakawa, E. C. Gabazza, S. Murashima, K. Morioka, N. Kitagawa, T. Tanaka, R. Araki-Sasaki, Y. Hori, et al. Neither Homeostasis Model Assessment nor Quantitative Insulin Sensitivity Check Index Can Predict Insulin Resistance in Elderly Patients with Poorly Controlled Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5332 - 5335. [Abstract] [Full Text] [PDF]

				G. I. Uwaifo, E. M. Fallon, J. Chin, J. Elberg, S. J. Parikh, and J. A. Yanovski Indices of Insulin Action, Disposal, and Secretion Derived From Fasting Samples and Clamps in Normal Glucose-Tolerant Black and White Children Diabetes Care, November 1, 2002; 25(11): 2081 - 2087. [Abstract] [Full Text] [PDF]

				E. H Serne, R. G Ijzerman, R. T de Jongh, and C. D.A Stehouwer Blood pressure and insulin resistance: role for microvascular function?: [Cardiovasc Res 2002;53:271-276] Cardiovasc Res, August 1, 2002; 55(2): 418 - 419. [Full Text] [PDF]

				A. Katsuki, Y. Sumida, E. C. Gabazza, S. Murashima, H. Urakawa, K. Morioka, N. Kitagawa, T. Tanaka, R. Araki-Sasaki, Y. Hori, et al. QUICKI Is Useful for Following Improvements in Insulin Sensitivity after Therapy in Patients with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2906 - 2908. [Abstract] [Full Text] [PDF]

				M. J. Quon QUICKI Is a Useful and Accurate Index of Insulin Sensitivity J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 949 - 950. [Full Text]

				G. E. Duncan, A. D. Hutson, and P. W. Stacpoole QUICKI Is Not a Useful and Accurate Index of Insulin Sensitivity following Exercise Training J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 950 - 951. [Full Text]